{"name":"SEED Therapeutics, Inc.","slug":"seed-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxOZW45NnQ4bVFRNEZseFNpcDg5ZlVjdWpGYnozeU03Qk9OWnRUalk3U09yUGdmOEp6Q2RoWVZJSVhNNE9mek1zaWQzTGNILTBsLWZ5ZmIxUXNPX1A4Y3hydlotMUJSMGVva0V3YjRobHZCeVlZSzhrYVJEalpyMWlVR0RHM3RWVldYRWdUQWxRVGRsekI1X0lqMl9hU1Q4WEdZLWN0RS14Tmk2ZElzRUFGbTZwaWprYk1iRE54c0ZFNHNFWS1Kbk5oT3RoR0tvX202SnZrR3BoTlR0Y0pkYXZRZ0cySDllU3owaGI1YWRyY0FzbXdzV09RSGlhTm1rMmdPWUk0bTdsb2VTU0RGaGRjeHRXRTZoenpmbVNXNWVsclZCTTR0SnJGcUlRQXNoblNSaWwyeWVsYTVzNXVEZ1J5aUljNmlzUmp6RzIzQ1JPYnA?oc=5","date":"2026-04-05","type":"pipeline","source":"MSN","summary":"SEED Therapeutics Names Dr. Bill Desmarais as CFO and CBO - MSN","headline":"SEED Therapeutics Names Dr. Bill Desmarais as CFO and CBO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNaF9WeWJrNkV5NnRhVmg3UER5a1FKdGlZZ001dk1tQUNWck1YWmFyZy1XRVd6RWxocjFGU0hqUncyY0gzeVlWSktaX3VaSGdFSW5zcUh6MkdDSHhhQkFkV0FaODlRZTdzYnlCTWxUc1J0YWE5M08xd1htX2tuUVNWX0xMMGNXY0lWOTNiWURteHlxOTNBVHBkVVhkMS1XMzFrMUZnckk0WUU5Y3hNalEwZWIwMDFtRkFGc2JhaF9TVEl1OW1HZUh3UnMyNDZaRUFWV1ozR2NxUFRaa1V5ZjBCUg?oc=5","date":"2026-03-30","type":"pipeline","source":"globenewswire.com","summary":"SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026 - globenewswire.com","headline":"SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPTTRkMHJiRnRJY2hIa09KTEVRZURZN0UwcjBzTC1JeDl3anlxRmZ1d3pLRm9jM21MUk5uY21ocUJXWXo4aFZiV0h0bi1oMWxVN28tdFY2VERMNVkxNFJ3ZTVKM1J3ZVk5eDZUWlk0eC1OU0M4ZnJfbWtSUnRBemVuanZmSkNwM0JUYk1USXJQdndlZjVuZ3lXcjg0QXRSU0ZRSWhrLXpLc2hJeXgzX2J6N3dKWnRmb25Ic0JUOGRIUmhpRUl1YTVGV1BzUGc4TlRFeHdXQlpDTVpaa0NpTEVsd2NxcHJJNURjdlE?oc=5","date":"2026-03-18","type":"pipeline","source":"Pharmaceutical Executive","summary":"Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing - Pharmaceutical Executive","headline":"Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOcU1JTE52OGVzUmJLYUZzaElqUkR5ZjNkVTBTQmQ3czhfTHVsVU5hTUJIdnZzREgyNFEtc2Rwd2tWeFJFSy1FYUFjdVpoTE1QNlpncnpaY2Vrd1ZHdFRiem5CNWkxclU5dW1JLTJyZE9pWXE2Qjc0dE1qVzNwaDg1SEJwaGFIMDNCZ1RPNjlaamVFc1cwVVBSc1draTAySlp3bmlTRnR4cnNfajBtNHI0S2twSHZLSW1rLW96VnFBNUdtOUkxSTk4TzMyVUhST1NoaFNUc1l5ejN2Ty16SmN0ZWVXc0JHdVk?oc=5","date":"2025-12-02","type":"pipeline","source":"Business Wire","summary":"Lyric Bio, Inc. Closes $6.6 Million Seed Financing To Revolutionize Donor-Derived Therapeutics - Business Wire","headline":"Lyric Bio, Inc. Closes $6.6 Million Seed Financing To Revolutionize Donor-Derived Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPejFlVktURTNWeFc1YXE3UmluLV9NVTRtSUlRWXVyZTVvb29LUkVKQS1KVnhsU3hsVnk3QVVNTjlZeVp0NjZzU2h3bEl4Y0lKMzdub25ramJ2d3lfY0NxbXI4b0RpZ05yV3lQbzR6ZVAwanc1VTAwUGlyTFJMbndmd2VJRkk4aU9wa29vTFQzNXowU0tSLWJyOVBfQm9iYXRTTmhFdWl6c3VUVFNlY3dRbEZPUXBRdElfN1E?oc=5","date":"2025-09-30","type":"deal","source":"Fierce Biotech","summary":"Novo dumps cell therapy partner Heartseed, calling off $598M collab amid restructuring - Fierce Biotech","headline":"Novo dumps cell therapy partner Heartseed, calling off $598M collab amid restructuring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOUDB3amt1eTRSWldnZTRZZ0hQMW1CQkFoN2NjQ0psVDVqd1RUbS1rTDJRbnByajZ2X1d6bWctZmNjNS03X1Z3aENkek9EbGVEcVQ2MGhocERpdVlvelVINWFhem5FNi1nUFN3WW9lVE85TjZPZ2gtWVNsX0xXQjlzOGhCM0NZd1lMZ0hBQ0dJd2VwRW9iMWZVb3drWm14VUNGUzV4aWFxQ3FESThVY0p2QjdBQmU1ZmMwZXkxLU1aTEJqdkN1a1E?oc=5","date":"2025-09-29","type":"pipeline","source":"Business Wire","summary":"Aarvik Therapeutics Announces Successful Series Seed 2 Financing Round - Business Wire","headline":"Aarvik Therapeutics Announces Successful Series Seed 2 Financing Round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQVlgyZjlGLW10UUQ4SVlfdk5wajZ0dHZ2dzdDWVlIa0RYUEtZalQxMTNxaG9saHJ1dTZsbG51eFVuMlI3WjBtcG1zX1dwRm9RcExYTV9Wa0Z3dV93Uy1ra2V2eE0yWTB4Y2x3WGVjbmVleC0zTU56VEROMWdxY3YyaWZJZXNwNEpQNlZ4OHpZeTRUT2t1eW0xLVMxTlluZEl1VDRMYWFydWlyOEJDdGpaYWZRTXFqZndYNWFjbm50Qm5zRXV1VDRVQjRhUQ?oc=5","date":"2025-09-23","type":"pipeline","source":"globenewswire.com","summary":"SEED Therapeutics Completes $30 Million Series A-3 Financing - globenewswire.com","headline":"SEED Therapeutics Completes $30 Million Series A-3 Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPbV9MQTU0V0k2UlVyVllBb1FaR2ZfWnFwU3ZBNWtCQnBBNlVCTHVCVVZlNERIQlJ0X2tUWkZuT2diSmdablpBeVA1di1WSHlHS1hfeEM4WXlLQi1LUEdLNVhSbGo5T3N0eEs1WXRJZ3g5MjlSbFU2SWRwWDRyd1JxdW9EamY?oc=5","date":"2025-08-11","type":"regulatory","source":"Yahoo Finance","summary":"FDA Clears IND for SEED Therapeutics’ RBM39 Degrader ST-01156 - Yahoo Finance","headline":"FDA Clears IND for SEED Therapeutics’ RBM39 Degrader ST-01156","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOS0VCTDNLeUFnZGJNUlN2TkJTSzkxZTJnNTRrS3JRVE5DLWlmaUdqeWxBUzdySFZ6UlRwQ3NQYmVEOGFyS2h4NGJYR2dLdEs2eVBEUkRLWG1CbFlTTzVSRXlBc1AteVlXbC1FUndlVlBNT0ZiQ3Flc3J3U21QUzdtWVRlbV9qVEk?oc=5","date":"2025-07-10","type":"pipeline","source":"BioPharma Dive","summary":"Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding - BioPharma Dive","headline":"Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNbnFhNHgxSG1VNVR1Mm5aUFJVVnV4aWd5NEExREhGTU8zak1PaUhOLUlYa1A1aDh5bm03SVpYWFpZbXVvaUZpVWtwMlZvT1VCekRMOWo5ekpjUW1RTXA4aVlpQl8tUmdmdVgyZDljRmJYZ2dtVEJuVlEwYUx0VEJrcTMxTTk0X0hzN0o5SjhTZzgwNzk2czFFRVJET0VGMXlyUS1QTUhNUkxMQkoyMkVNbjF1UVVCMTRGQ09vY2gtc0JmV3RvZEZrSEo0MVVSSzhhTUZhOXJrVHFBUmg2RDBIUi1oRFFmbzNqRkE2SnRJOGpwSkpwQjdzc09wLVFUX2ZMcUVtaVJWSQ?oc=5","date":"2025-03-03","type":"trial","source":"PR Newswire","summary":"Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies - PR Newswire","headline":"Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOYWxyMjdaUWVXRzdRcGxidUtTWm1lamw4Z0tmYWpHTTFwUy12MHd5SERmc0JFcXNJSmZDN1gxMkJWUlU0QUdjSklwZGtPN0l4NFJ3WkRLdXUyLWFhc1F5XzUtRi05aUljVWdHMkFKbmNsbWRHWVI4RktfWWl2YjRxM00tRUZJUHlVemlPaFAtUGdhVmxTQ3lndDh3d3Vsc1ItTjQzaXd5VDlKMGExcDY4?oc=5","date":"2024-08-08","type":"deal","source":"The Business Journals","summary":"Seed Therapeutics enters into collaboration deal valued at up to $1.5B with Japan-based Eisai - The Business Journals","headline":"Seed Therapeutics enters into collaboration deal valued at up to $1.5B with Japan-based Eisai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQVXlCVXpmME9KSUZOZ0xDRU1TSEVwSE5sM0tfWldEczB6VUZBZDVKbW5JSXNoazV6UkYxbllEQnBQMG9nTGxBY29hQUZrOU84WldmZ3VBSlExM0FiOElOSDMzVGY5LVQtR0cyb0pTbzJmZ0NPVVFXempEZDd1X25TajYzakctLUdCdFdzOFN3?oc=5","date":"2024-08-06","type":"deal","source":"Yahoo Finance","summary":"SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications - Yahoo","headline":"SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}